We report, for the first time, that DHA supplementation during pregnancy in women with obesity normalizes the increased IGF2R levels in male placentas, reducing the risk of adverse outcomes related to the IGF2/IGF2R system in male newborns. This evidence concerns the gene IGF2R and obesity due to melanocortin 4 receptor deficiency.